Timothy Chiang analyst CAPITAL ONE

Covered Stocks

Timothy Chiang

Work

Analyst Timothy Chiang works at CAPITAL ONE and is focused on the Healthcare sector with 132 price targets and ratings documented since 2016 spanning on 9 stocks. Previously, Timothy Chiang worked at BTIG. Analyst's average stock valuation to be materialised ratio is 24.23% with an average time for price targets to be met of 117.92 days.

Most recent stock forecast was given on AMPH, Amphastar Pharmaceuticals, Inc at 29-Jul-2022.

Timothy Chiang best performing recommendations are on PCRX (PACIRA BIOSCIENCES, INC).
The best stock recommendation documented was for TEVA (TEVA PHARMACEUTICAL INDUSTRIES LIMITED) at 2/14/2017. The price target of $34 was fulfilled within 1 day with a profit of $0.24 (0.71%) receiving and performance score of 7.11.

Average potential price target upside

AMPH EYEN IRWD MYL RLYP SGYP SRPT TEVA VTRS
AMPH EYEN IRWD MYL RLYP SGYP SRPT TEVA VTRS